BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8675819)

  • 1. Anti-lipase activity of Kampo formulations, coptidis rhizoma and its alkaloids against Propionibacterium acnes.
    Higaki S; Nakamura M; Morohashi M; Hasegawa Y; Yamagishi T
    J Dermatol; 1996 May; 23(5):310-4. PubMed ID: 8675819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of coptidis rhizoma to lipase activity of Propionibacterium acnes].
    Higaki S; Hasegawa Y; Morohashi M; Sakamoto K; Yamagishi T
    Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):883-6. PubMed ID: 2232295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation of Kampo formulations and their ingredients on anti-bacterial activities against Propionibacterium acnes.
    Higaki S; Hasegawa Y; Morohashi M; Takayoshi Y
    J Dermatol; 1995 Jan; 22(1):4-9. PubMed ID: 7897023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of eleven kampo formulations and eight kampo crude drugs against Propionibacterium acnes isolated from acne patients: retrospective evaluation in 1990 and 1995.
    Higaki S; Nakamura M; Morohashi M; Hasegawa Y; Yamagishi T
    J Dermatol; 1996 Dec; 23(12):871-5. PubMed ID: 9037918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Propionibacterium acnes biotypes and Jumi-haidoku-to.
    Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
    J Dermatol; 2000 Oct; 27(10):635-8. PubMed ID: 11092266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lipase activities of Propionibacterium granulosum and Propionibacterium acnes.
    Higaki S; Nakamura M; Kitagawa T; Morohashi M; Yamagishi T
    Drugs Exp Clin Res; 2001; 27(5-6):161-4. PubMed ID: 11951573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propionibacterium acnes lipase in seborrheic dermatitis and other skin diseases and Unsei-in.
    Higaki S; Morohashi M
    Drugs Exp Clin Res; 2003; 29(4):157-9. PubMed ID: 15018307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations.
    Higaki S; Morimatsu S; Morohashi M; Yamagishi T; Hasegawa Y
    J Int Med Res; 1997; 25(6):318-24. PubMed ID: 9427165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
    Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propionibacterium acnes biotypes and susceptibility to minocycline and Keigai-rengyo-to.
    Higaki S; Nakamura M; Morohashi M; Yamagishi T
    Int J Dermatol; 2004 Feb; 43(2):103-7. PubMed ID: 15125499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
    Unno M; Cho O; Sugita T
    Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Propionibacterium acnes lipase by extracts of Indian medicinal plants.
    Patil V; Bandivadekar A; Debjani D
    Int J Cosmet Sci; 2012 Jun; 34(3):234-9. PubMed ID: 22268921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-lipase activity of shiunko on Propionibacterium acnes.
    Higaki S; Morimatsu S; Morohashi M; Yamagishi T
    Int J Antimicrob Agents; 1998 Aug; 10(3):251-2. PubMed ID: 9832288
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M; Wasik B; Becker A; Höffler U
    Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between Propionibacterium acnes biotypes, lipase activity and rash degree in acne patients.
    Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
    J Dermatol; 2000 Aug; 27(8):519-22. PubMed ID: 10989576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
    Akamatsu H; Tomita T; Horio T
    Dermatology; 2002; 204(4):277-80. PubMed ID: 12077521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exoenzymes of Propionibacterium acnes.
    Kabongo Muamba ML
    Can J Microbiol; 1982 Jul; 28(7):758-61. PubMed ID: 7172137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Total alkaloids of Coptidis Rhizoma combined with exercise inhibits tumor growth of orthotopically transplanted 4T1 breast cancer mice by blocking cell cycle G_1/S transformation].
    Wang B; Xu SY; Liu JX; Li YF; Xu HS; Han B; Zhang J; Li XG; Ye XL
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1635-1641. PubMed ID: 31090328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhodomyrtone inhibits lipase production, biofilm formation, and disorganizes established biofilm in Propionibacterium acnes.
    Wunnoo S; Saising J; Voravuthikunchai SP
    Anaerobe; 2017 Feb; 43():61-68. PubMed ID: 27923605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition.
    Lee WL; Shalita AR; Suntharalingam K; Fikrig SM
    Infect Immun; 1982 Jan; 35(1):71-8. PubMed ID: 7054130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.